| 摘要 |
Compounds of formula (I) in salt or zwitterionic form, wherein R 1, R2, R3, R4 and R5 have the meanings as indicated in the specification, are useful for treating conditions that are mediated by the muscarinic M3 receptor. Pharmaceutical compositions that contain the compounds and a process for preparing the compounds are also described. |
